148 related articles for article (PubMed ID: 12688394)
1. Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors.
Yasunari K; Maeda K; Nakamura M; Yoshikawa J
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S33-8. PubMed ID: 12688394
[TBL] [Abstract][Full Text] [Related]
2. Anti-atherosclerotic action of vascular D1 receptors.
Yasunari K; Kohno M; Kano H; Hanehira T; Minami M; Yoshikawa J
Clin Exp Pharmacol Physiol Suppl; 1999 Apr; 26():S36-40. PubMed ID: 10386252
[TBL] [Abstract][Full Text] [Related]
3. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors.
Yasunari K; Kohno M; Kano H; Minami M; Yoshikawa J
Circulation; 2000 May; 101(19):2302-8. PubMed ID: 10811599
[TBL] [Abstract][Full Text] [Related]
4. Dopamine as a novel antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1-like receptors.
Yasunari K; Kohno M; Hasuma T; Horio T; Kano H; Yokokawa K; Minami M; Yoshikawa J
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3164-73. PubMed ID: 9409307
[TBL] [Abstract][Full Text] [Related]
5. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
Geraldes P; Sirois MG; Tanguay JF
Circ Res; 2003 Sep; 93(5):399-405. PubMed ID: 12893737
[TBL] [Abstract][Full Text] [Related]
6. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of atrial natriuretic peptide (ANP) C receptor expression by antisense oligodeoxynucleotides in A10 vascular smooth-muscle cells is associated with attenuation of ANP-C-receptor-mediated inhibition of adenylyl cyclase.
Palaparti A; Li Y; Anand-Srivastava MB
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):313-20. PubMed ID: 10677348
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells.
Chandra A; Angle N
Surgery; 2005 Oct; 138(4):780-7. PubMed ID: 16269309
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human vascular smooth muscle cell migration by beta-adrenergic receptors.
Johnson R; Webb JG; Newman WH; Wang Z
Am Surg; 2006 Jan; 72(1):51-4. PubMed ID: 16494183
[TBL] [Abstract][Full Text] [Related]
10. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].
Bian J; Zhang B; Chen S
Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):10-4. PubMed ID: 11600998
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain.
Nash SR; Godinot N; Caron MG
Mol Pharmacol; 1993 Nov; 44(5):918-25. PubMed ID: 8246914
[TBL] [Abstract][Full Text] [Related]
12. D1A, D1B, and D1C dopamine receptors from Xenopus laevis.
Sugamori KS; Demchyshyn LL; Chung M; Niznik HB
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10536-40. PubMed ID: 7937989
[TBL] [Abstract][Full Text] [Related]
13. Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties.
Charpentier S; Jarvie KR; Severynse DM; Caron MG; Tiberi M
J Biol Chem; 1996 Nov; 271(45):28071-6. PubMed ID: 8910419
[TBL] [Abstract][Full Text] [Related]
14. Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice.
Montague DM; Striplin CD; Overcash JS; Drago J; Lawler CP; Mailman RB
Synapse; 2001 Mar; 39(4):319-22. PubMed ID: 11169782
[TBL] [Abstract][Full Text] [Related]
15. High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype.
Tiberi M; Caron MG
J Biol Chem; 1994 Nov; 269(45):27925-31. PubMed ID: 7525564
[TBL] [Abstract][Full Text] [Related]
16. [Effect of protein expression on antisense c-myc and PCNA for vascular smooth muscle cells].
Bian J; Zhang B; Qian H; Chen S
Zhonghua Wai Ke Za Zhi; 2000 Feb; 38(2):140-2. PubMed ID: 11832013
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1A receptors and renin release in rat juxtaglomerular cells.
Yamaguchi I; Yao L; Sanada H; Ozono R; Mouradian MM; Jose PA; Carey RM; Felder RA
Hypertension; 1997 Apr; 29(4):962-8. PubMed ID: 9095084
[TBL] [Abstract][Full Text] [Related]
18. Cudraflavanone A, a flavonoid isolated from the root bark of Cudrania tricuspidata, inhibits vascular smooth muscle cell growth via an Akt-dependent pathway.
Han HJ; Kim TJ; Jin YR; Hong SS; Hwang JH; Hwang BY; Lee KH; Park TK; Yun YP
Planta Med; 2007 Sep; 73(11):1163-8. PubMed ID: 17713875
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D1B receptor chimeras reveal modulation of partial agonist activity by carboxyl-terminal tail sequences.
Sugamori KS; Scheideler MA; Vernier P; Niznik HB
J Neurochem; 1998 Dec; 71(6):2593-9. PubMed ID: 9832160
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
